Experimental intracerebral hemorrhage: avoiding pitfalls in translational research

Area of Science:

• Neurology
• Stroke Research
• Preclinical Modeling

Background:

• Intracerebral hemorrhage (ICH) is the deadliest stroke subtype, with limited treatment options.
• Existing preclinical models of ICH fail to fully capture the complexity of human disease.
• Advances in understanding ICH pathophysiology have not translated into effective clinical treatments.

Purpose of the Study:

• To review current experimental models of intracerebral hemorrhage.
• To discuss limitations of existing ICH models and suggest improvements for laboratory studies.
• To emphasize the need for validated preclinical models to advance ICH treatment development.

Main Methods:

• Review and discussion of existing experimental intracerebral hemorrhage models.
• Analysis of the strengths and weaknesses of various ICH induction methods (e.g., blood injection, collagenase).
• Consideration of newly developed models, including those associated with hypertension and anticoagulation therapy.

Main Results:

• Current experimental ICH models partially replicate injury mechanisms but lack key clinical features.
• Newly developed models show promise but require further validation.
• Significant discrepancies exist between experimental findings and clinical outcomes, indicating a need for improved models.

Conclusions:

• Experimental models are crucial for understanding ICH pathophysiology, but their limitations must be acknowledged.
• Developing more accurate preclinical ICH models is essential for successful translation to clinical practice.
• Future neuroprotective agent trials should utilize multiple validated models and assess both histological and functional outcomes.